Morpholino T subunit
Employing cutting-edge science, this innovative compound showcases remarkable aptitude in the treatment of diverse ailments. By harnessing its potent therapeutic potential, it enables precise drug delivery to targeted areas and enables the implementation of gene therapy. Its exceptional molecular structure amplifies drug efficacy, empowering healthcare professionals to administer focused treatment for a wide array of medical conditions.
Catalog Number | PIPB-0327 |
Alternative Name(s) | ((2S,6R)-6-(5-Methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-tritylmorpholin-2-yl)methyl dimethylphosphoramidochloridate 956139-30-3 ((2S,6R)-6-(5-Methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-tritylmorpholin-2-yl)methyl (R)-dimethylphosphoramidochloridate 2077093-78-6 N,N-Dimethylphosphoramidochloridic Acid [(2S,6R)-6-(3,4-Dihydro-5-methyl-2,4-dioxo-1(2H)-pyrimidinyl)-4-(triphenylmethyl)-2-morpholinyl]methyl Ester |
Research Area | Phosphoramidites Series |
Molecular Formula | C31H34ClN4O5P |
CAS# | 956139-30-3 |
SMILES | CC1=CN(C(=O)NC1=O)C2CN(CC(O2)COP(=O)(N(C)C)Cl)C(C3=CC=CC=C3)(C4=CC=CC=C4)C5=CC=CC=C5 |
Size | inquiry |
Supplier Page | https://www.protheragen-ing.com/morpholino-t-subunit-item-10445.html |